Literature DB >> 22114304

Rac deletion in osteoclasts causes severe osteopetrosis.

Monica Croke1, F Patrick Ross, Matti Korhonen, David A Williams, Wei Zou, Steven L Teitelbaum.   

Abstract

Cdc42 mediates bone resorption principally by stimulating osteoclastogenesis. Whether its sister GTPase, Rac, meaningfully impacts upon the osteoclast and, if so, by what means, is unclear. We find that whereas deletion of Rac1 or Rac2 alone has no effect, variable reduction of Rac1 in osteoclastic cells of Rac2(-/-) mice causes severe osteopetrosis. Osteoclasts lacking Rac1 and Rac2 in combination (Rac double-knockout, RacDKO), fail to effectively resorb bone. By contrast, osteoclasts are abundant in RacDKO osteopetrotic mice and, unlike those deficient in Cdc42, express the maturation markers of the cells normally. Hence, the osteopetrotic lesion of RacDKO mice largely reflects impaired function, and not arrested differentiation, of the resorptive polykaryon. The dysfunction of RacDKO osteoclasts represents failed cytoskeleton organization as evidenced by reduced motility of the cells and their inability to spread or generate the key resorptive organelles (i.e. actin rings and ruffled borders), which is accompanied by abnormal Arp3 distribution. The cytoskeleton-organizing capacity of Rac1 is mediated through its 20-amino-acid effector domain. Thus, Rac1 and Rac2 are mutually compensatory. Unlike Cdc42 deficiency, their combined absence does not impact upon differentiation but promotes severe osteopetrosis by dysregulating the osteoclast cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22114304      PMCID: PMC3225269          DOI: 10.1242/jcs.086280

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  33 in total

1.  Rac1 is required for the formation of three germ layers during gastrulation.

Authors:  K Sugihara; N Nakatsuji; K Nakamura; K Nakao; R Hashimoto; H Otani; H Sakagami; H Kondo; S Nozawa; A Aiba; M Katsuki
Journal:  Oncogene       Date:  1998-12-31       Impact factor: 9.867

2.  Characterization of RAC3, a novel member of the Rho family.

Authors:  L Haataja; J Groffen; N Heisterkamp
Journal:  J Biol Chem       Date:  1997-08-15       Impact factor: 5.157

Review 3.  Osteopetrosis.

Authors:  Jakub Tolar; Steven L Teitelbaum; Paul J Orchard
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

Review 4.  Rho GTPases: biochemistry and biology.

Authors:  Aron B Jaffe; Alan Hall
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

5.  Vav3 regulates osteoclast function and bone mass.

Authors:  Roberta Faccio; Steven L Teitelbaum; Keiko Fujikawa; Jean Chappel; Alberta Zallone; Victor L Tybulewicz; F Patrick Ross; Wojciech Swat
Journal:  Nat Med       Date:  2005-02-13       Impact factor: 53.440

6.  Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal.

Authors:  Haibo Zhao; F Patrick Ross; Steven L Teitelbaum
Journal:  Mol Endocrinol       Date:  2004-12-09

7.  Deficiency of the hematopoietic cell-specific Rho family GTPase Rac2 is characterized by abnormalities in neutrophil function and host defense.

Authors:  A W Roberts; C Kim; L Zhen; J B Lowe; R Kapur; B Petryniak; A Spaetti; J D Pollock; J B Borneo; G B Bradford; S J Atkinson; M C Dinauer; D A Williams
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

8.  Arp2/3 complex from Acanthamoeba binds profilin and cross-links actin filaments.

Authors:  R D Mullins; J F Kelleher; J Xu; T D Pollard
Journal:  Mol Biol Cell       Date:  1998-04       Impact factor: 4.138

9.  Successful bone-marrow transplantation for infantile malignant osteopetrosis.

Authors:  P F Coccia; W Krivit; J Cervenka; C Clawson; J H Kersey; T H Kim; M E Nesbit; N K Ramsay; P I Warkentin; S L Teitelbaum; A J Kahn; D M Brown
Journal:  N Engl J Med       Date:  1980-03-27       Impact factor: 91.245

10.  Actin-related protein 2/3 complex is required for actin ring formation.

Authors:  I Rita Hurst; Jian Zuo; Jin Jiang; L Shannon Holliday
Journal:  J Bone Miner Res       Date:  2003-12-22       Impact factor: 6.741

View more
  44 in total

Review 1.  Osteoclasts: New Insights.

Authors:  Xu Feng; Steven L Teitelbaum
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

2.  Notch signaling inhibition protects against LPS mediated osteolysis.

Authors:  Peeyush N Goel; Alexander J Egol; Yasaman Moharrer; Beatrix Brandfield-Harvey; Jaimo Ahn; Jason W Ashley
Journal:  Biochem Biophys Res Commun       Date:  2019-06-05       Impact factor: 3.575

3.  Paxillin contracts the osteoclast cytoskeleton.

Authors:  Wei Zou; Carl J Deselm; Thomas J Broekelmann; Robert P Mecham; Scott Vande Pol; Kyunghee Choi; Steven L Teitelbaum
Journal:  J Bone Miner Res       Date:  2012-12       Impact factor: 6.741

4.  Activation of EPAC1/2 is essential for osteoclast formation by modulating NFκB nuclear translocation and actin cytoskeleton rearrangements.

Authors:  Aránzazu Mediero; Miguel Perez-Aso; Bruce N Cronstein
Journal:  FASEB J       Date:  2014-08-13       Impact factor: 5.191

Review 5.  Importance of RhoGTPases in formation, characteristics, and functions of invadosomes.

Authors:  Pirjo Spuul; Paolo Ciufici; Véronique Veillat; Anne Leclercq; Thomas Daubon; IJsbrand Kramer; Elisabeth Génot
Journal:  Small GTPases       Date:  2014-05-08

Review 6.  Modulation of osteoclast differentiation and bone resorption by Rho GTPases.

Authors:  Heiani Touaitahuata; Anne Blangy; Virginie Vives
Journal:  Small GTPases       Date:  2014-03-10

Review 7.  Podosome organization drives osteoclast-mediated bone resorption.

Authors:  Dan Georgess; Irma Machuca-Gayet; Anne Blangy; Pierre Jurdic
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

8.  c-Src links a RANK/αvβ3 integrin complex to the osteoclast cytoskeleton.

Authors:  Takashi Izawa; Wei Zou; Jean C Chappel; Jason W Ashley; Xu Feng; Steven L Teitelbaum
Journal:  Mol Cell Biol       Date:  2012-05-21       Impact factor: 4.272

9.  Talin1 and Rap1 are critical for osteoclast function.

Authors:  Wei Zou; Takashi Izawa; Tingting Zhu; Jean Chappel; Karel Otero; Susan J Monkley; David R Critchley; Brian G Petrich; Alexei Morozov; Mark H Ginsberg; Steven L Teitelbaum
Journal:  Mol Cell Biol       Date:  2012-12-10       Impact factor: 4.272

10.  Zap70 inhibits Syk-mediated osteoclast function.

Authors:  Wei Zou; Monica Croke; Tomohiro Fukunaga; Thomas J Broekelmann; Robert P Mecham; Steven L Teitelbaum
Journal:  J Cell Biochem       Date:  2013-08       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.